CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 128 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,185 | -23.7% | 145,910 | +11.1% | 0.00% | -33.3% |
| Q2 2023 | $4,175 | -71.5% | 131,342 | -78.1% | 0.00% | -57.1% |
| Q1 2023 | $14,660 | +1.8% | 601,054 | +31.6% | 0.01% | +16.7% |
| Q4 2022 | $14,402 | -99.5% | 456,615 | +367.2% | 0.01% | +100.0% |
| Q3 2022 | $2,762,000 | +3632.4% | 97,735 | +3371.9% | 0.00% | – |
| Q2 2022 | $74,000 | -69.0% | 2,815 | -58.7% | 0.00% | – |
| Q1 2022 | $239,000 | – | 6,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |